An endometrial thickness of
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2025
DOI: 10.1111/ajo.13900 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2025. Verfasst von Sae Jin Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Middlemore Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Endometrium, Endometrial Neoplasms, Uterine Hemorrhage, Precancerous Conditions. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
It remains unclear if there is an endometrial thickness (ET) threshold below which malignancy can be excluded. Guidance on whether endometrial biopsy is needed based on ET varies among regions in New Zealand and there is a desire to standardise guidance nationwide. This study evaluates the potential impact of limiting endometrial biopsy in pre‐menopausal persons with abnormal uterine bleeding (AUB) to those with an ET of less than 12 mm.
Aims
To determine the number of pre‐menopausal patients with AUB with an ET of less than 12 mm undergoing endometrial sampling annually and assess the prevalence of pathology among these patients. Materials and Methods Endometrial samples from patients aged 18–50 years processed at a tertiary hospital between 15/06/2022 and 13/06/2023 were identified via a pathology lab search. Clinical, radiologic, and pathological data were obtained by case note review for those with AUB whose ET was less than 12 mm.
Results
Of 1271 endometrial samples, 355 patients met the eligibility criteria, and 2.2% of these were cancerous (three cases) or pre‐malignant (five cases).
Conclusions
If sampling thresholds would change to not perform biopsies in those with an ET of less than 12 mm, eight cases of treatable disease would be missed in pre‐menopausal people. This represents 13.6% of all endometrial cancers diagnosed in pre‐menopausal people in the same time period. There is no ET cut‐off to reliably exclude high‐risk pathology and endometrial sampling should be performed in all cases of AUB with risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Middlemore Hospital, Auckland, New Zealand.
- Department of Histopathology, Middlemore Hospital, Auckland, New Zealand.
- Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Obstetrics and Gynaecology, Te Toka Tumai, Auckland, New Zealand.
ORCID-Profile: Sae Jin Song, Charlotte Oyston
Zitieren
APA
Song, S. J., Miles, C., Ponnampalam, S., Sowden, K., Shafique, A., & Oyston, C. (2025). An endometrial thickness of. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13900
Vancouver
Song SJ, Miles C, Ponnampalam S, Sowden K, Shafique A, Oyston C. An endometrial thickness of. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2025. doi:10.1111/ajo.13900
BibTeX
@article{Song2025,
author = {Song, Sae Jin and Miles, Carina and Ponnampalam, Sathana and Sowden, Katherine and Shafique, Asima and Oyston, Charlotte},
title = {An endometrial thickness of},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2025},
doi = {10.1111/ajo.13900}
}
EUVIMED